Pharmacy

More Articles ...

More Articles ...

The FINANCIAL -- Amgen on March 29 announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for BLINCYTO (blinatumomab) for the ...

The FINANCIAL -- Johnson & Johnson on April 17 announced sales of $20.0 billion for the first quarter of 2018, an increase of 12.6% as compared to the first quarter of ...